David D. Spragg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David D. Spragg has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Joseph E. Marine
Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
21 shared publications - Hugh Calkins
Johns Hopkins University Hospital, Baltimore, Maryland, USA
18 shared publications - Ronald D. Berger
Johns Hopkins Medicine Division of Cardiology
14 shared publications Hugh Calkins
Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD
12 shared publicationsJoseph E. Marine
Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD
9 shared publications- Hiroshi Ashikaga
IHU Liryc, Electrophysiology and Heart Modeling Instituté, fondation Bordeaux Université, F-33600 Pessac-Bordeaux, France
7 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (4)
Relationships between three-dimensional fibrosis distribution, atrial adiposity, and voltage abnormalities associated with persistent atrial fibrillation
Persistent atrial fibrillation (PsAF) is often refractory to pulmonary vein isolation, a well-established AF treatment, owing to the fibrosis-remodeled substrates sustaining reentries. Three-dimensional fibrosis distribution and atrial adiposity have been found to be essential contributors to PsAF arrhythmogenesis. We aimed to utilize late gadolinium enhancement (LGE)-MRI-derived personalized heart digital twins (DTs)—a recent promising tool for non-invasively assessing patient arrhythmogenesis—as well as contrast-enhanced cardiac computed tomography (CCT) images and electroanatomic maps (EAMs) to investigate relationships between fibrosis distribution, including endo–epi differences, adiposity infiltration, and electrophysiological abnormalities, and their influence on PsAF arrhythmogenic substrate. DTs incorporating fibrosis distribution were generated from consecutive PsAF patients’ LGE-MRIs. Using rapid pacing, potential locations attracting reentries (LRs) were identified in DTs. CCTs were used to segment adipose tissue within pericardial sac and evaluate the distance from endocardial surface to closest adipose tissue (DEnCA). Bipolar- and unipolar-low-voltage area fractions (LVFs) were extracted from EAMs. Volumetric fibrosis fraction (FF) and surface FF on endocardial and epicardial surfaces at LRs and non-LRs were analyzed in relation to DEnCA and LVF. In 22 patients, adipose tissue volume correlated with BMI and CHA2DS2-VASc and, together with atrial-FF, predicted number of LRs. At LRs and non-LRs, while volumetric-FF was the sole determinant of LR classification, volumetric-FF correlated with endocardium-predominant fibrosis and bipolar-LVF. Endocardium-predominant fibrosis was independently linked to DEnCA. This study highlights the complex interactions between structural features, such as three-dimensional fibrosis distribution and atrial adiposity infiltration, electrophysiological features, and PsAF arrhythmogenesis.
- 27 March 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (4)
Open AccessRelationships between three-dimensional fibrosis distribution, atrial adiposity, and voltage abnormalities associated with persistent atrial fibrillation
Persistent atrial fibrillation (PsAF) is often refractory to pulmonary vein isolation, a well-established AF treatment, owing to the fibrosis-remodeled substrates sustaining reentries. Three-dimensional fibrosis distribution and atrial adiposity have been found to be essential contributors to PsAF arrhythmogenesis. We aimed to utilize late gadolinium enhancement (LGE)-MRI-derived personalized heart digital twins (DTs)—a recent promising tool for non-invasively assessing patient arrhythmogenesis—as well as contrast-enhanced cardiac computed tomography (CCT) images and electroanatomic maps (EAMs) to investigate relationships between fibrosis distribution, including endo–epi differences, adiposity infiltration, and electrophysiological abnormalities, and their influence on PsAF arrhythmogenic substrate. DTs incorporating fibrosis distribution were generated from consecutive PsAF patients’ LGE-MRIs. Using rapid pacing, potential locations attracting reentries (LRs) were identified in DTs. CCTs were used to segment adipose tissue within pericardial sac and evaluate the distance from endocardial surface to closest adipose tissue (DEnCA). Bipolar- and unipolar-low-voltage area fractions (LVFs) were extracted from EAMs. Volumetric fibrosis fraction (FF) and surface FF on endocardial and epicardial surfaces at LRs and non-LRs were analyzed in relation to DEnCA and LVF. In 22 patients, adipose tissue volume correlated with BMI and CHA2DS2-VASc and, together with atrial-FF, predicted number of LRs. At LRs and non-LRs, while volumetric-FF was the sole determinant of LR classification, volumetric-FF correlated with endocardium-predominant fibrosis and bipolar-LVF. Endocardium-predominant fibrosis was independently linked to DEnCA. This study highlights the complex interactions between structural features, such as three-dimensional fibrosis distribution and atrial adiposity infiltration, electrophysiological features, and PsAF arrhythmogenesis.
- 5 March 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (4) , 836-838
Beyond Recurrence
- 5 March 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (4) , 836-838
Beyond Recurrence
- 27 November 2025
- Published by Elsevier in Heart Rhythm
- Vol. 23 (4) , e567-e576
Trends of single-center complication rates for catheter ablation of atrial fibrillation from 2015 to 2024
- 27 November 2025
- Published by Elsevier in Heart Rhythm
- Vol. 23 (4) , e567-e576
Trends of single-center complication rates for catheter ablation of atrial fibrillation from 2015 to 2024
- 28 August 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (11) , 2436-2444
Social Determinants of Health and Disparities in Diagnosis-to-Ablation Time for Atrial Fibrillation
- 28 August 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (11) , 2436-2444
Social Determinants of Health and Disparities in Diagnosis-to-Ablation Time for Atrial Fibrillation
- 29 May 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (6) , 1087-1089
First-Line Ablation for Persistent AF
- 29 May 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (6) , 1087-1089
First-Line Ablation for Persistent AF
- 22 May 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (8) , 1848-1855
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation
- 22 May 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (8) , 1848-1855
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation
- 29 November 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (2) , 262-269
Pericarditis After Catheter Ablation for Atrial Fibrillation
- 29 November 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (2) , 262-269
Pericarditis After Catheter Ablation for Atrial Fibrillation
- 27 June 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (8) , 1640-1647
Sex‐based differences in safety and efficacy of catheter ablation for atrial fibrillation
Background: Studies have identified significant sex‐based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of sex on the outcome and safety of ablation procedures is still unclear.Objective: To investigate sex‐based differences in outcomes and complications after AF catheter ablation, with a significant female cohortMethod: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications.Results: Total of 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2 vs. 62.4 years; p < .001). Women had higher CHA2DS2‐VASc (congestive heart failure, hypertension, age, diabetes, stroke, vascular disease, sex category) scores (3 vs. 2; p < .001) than men, expectedly, as the female sex warrants an additional point. 25.3% female patients had PersAF at the time of diagnosis versus 35.3% male patients (p < .001). At the time of ablation, 31.8% female patients had PersAF as compared to 43.1% male patients (p < .001), indicating progression of PAF to PersAF in both sexes. Women tried more AADs than men before ablation (1.13 vs. 0.98; p = .002). Male and female patients had no statistically significant difference in (a) arrhythmia recurrence at 1‐year post ablation (27.7% vs. 30%; p = .38) or (b) procedural complication rate (1.8% vs. 3.1%; p = .56).Conclusion: Female patients were older and had higher CHA2DS2‐VASc scores compared to males at the time of AF ablation. Women tried more AADs than men before ablation. One‐year arrhythmia recurrence rates and procedural complications were similar in both sexes. No sex‐based differences were observed in safety and efficacy of ablation.
- 27 June 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (8) , 1640-1647
Sex‐based differences in safety and efficacy of catheter ablation for atrial fibrillation
Background: Studies have identified significant sex‐based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of sex on the outcome and safety of ablation procedures is still unclear.Objective: To investigate sex‐based differences in outcomes and complications after AF catheter ablation, with a significant female cohortMethod: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications.Results: Total of 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2 vs. 62.4 years; p < .001). Women had higher CHA2DS2‐VASc (congestive heart failure, hypertension, age, diabetes, stroke, vascular disease, sex category) scores (3 vs. 2; p < .001) than men, expectedly, as the female sex warrants an additional point. 25.3% female patients had PersAF at the time of diagnosis versus 35.3% male patients (p < .001). At the time of ablation, 31.8% female patients had PersAF as compared to 43.1% male patients (p < .001), indicating progression of PAF to PersAF in both sexes. Women tried more AADs than men before ablation (1.13 vs. 0.98; p = .002). Male and female patients had no statistically significant difference in (a) arrhythmia recurrence at 1‐year post ablation (27.7% vs. 30%; p = .38) or (b) procedural complication rate (1.8% vs. 3.1%; p = .56).Conclusion: Female patients were older and had higher CHA2DS2‐VASc scores compared to males at the time of AF ablation. Women tried more AADs than men before ablation. One‐year arrhythmia recurrence rates and procedural complications were similar in both sexes. No sex‐based differences were observed in safety and efficacy of ablation.
- Open Access
- 13 April 2023
- Published by Wiley
Sex- Based Differences in Safety and Efficacy of Catheter Ablation for Atrial Fibrillation
Background: Studies have identified significant sex-based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of gender on the outcome and safety of ablation procedures is still unclear. Objective: To investigate sex-based differences in outcomes and complications after AF catheter ablation, with a significant size female cohort Method: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications. Results: Total 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2y vs 62.4y; p2 DS 2 -VASc scores (3 vs 2; pConclusion: Female patients were older and had higher CHA 2 DS 2 -VASc scores compared to males at the time of AF ablation. Women tried more AADs than men prior to ablation. 1-y arrhythmia recurrence rates and procedural complications were similar in both genders. No sex- based differences were observed in safety and efficacy of ablation.
- 13 April 2023
- Published by Wiley
Open AccessSex- Based Differences in Safety and Efficacy of Catheter Ablation for Atrial Fibrillation
Background: Studies have identified significant sex-based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of gender on the outcome and safety of ablation procedures is still unclear. Objective: To investigate sex-based differences in outcomes and complications after AF catheter ablation, with a significant size female cohort Method: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications. Results: Total 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2y vs 62.4y; p2 DS 2 -VASc scores (3 vs 2; pConclusion: Female patients were older and had higher CHA 2 DS 2 -VASc scores compared to males at the time of AF ablation. Women tried more AADs than men prior to ablation. 1-y arrhythmia recurrence rates and procedural complications were similar in both genders. No sex- based differences were observed in safety and efficacy of ablation.
- 27 February 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (2) , 189-191
PVC-Induced Cardiomyopathy
- 27 February 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (2) , 189-191
PVC-Induced Cardiomyopathy